Founder & Former CEO
IntelliCyt Corporation
Education
M.S. – Electrical Engineering, Arizona State University
B.S. – Electrical Engineering, University of Pittsburgh
Business/Research Background
Mr. Dunlay is a seasoned life science entrepreneur with over three decades of experience transforming cutting-edge technologies into successful commercial ventures.
He is the founder and former CEO of IntelliCyt Corporation, where he led the development and commercialization of high-throughput cell analysis systems that help accelerate life science research and drug discovery. Under his leadership, IntelliCyt grew from a University of New Mexico spin-out to a global technology provider and was acquired by international laboratory equipment supplier Sartorius AG in 2016. Prior to that, he co-founded Cellomics, an early pioneer in high-content cellular imaging instrumentation, which was acquired by Thermo Fisher Scientific in 2005.
Earlier, he played key roles at two Carnegie Mellon–affiliated startups—serving as founder and CEO of Biological Detection, Inc. and Vice President of Engineering at Biological Detection Systems. He began his life sciences journey at Cytyc Corporation in Boston.
Mr. Dunlay’s career began in artificial intelligence and engineering roles, where he developed computer vision algorithms for some of the earliest self-driving vehicles at Lockheed Martin and created industrial automation systems at PPG Industries. He holds both a BS and MS in Electrical Engineering and is the inventor on numerous patents in cell-based screening instrumentation and informatics.
Particular Knowledge and Skills
Throughout his career, Mr. Dunlay has combined technical expertise with entrepreneurial vision, building companies whose innovations have advanced biomedical research worldwide. Today, he applies his experience and insights as an advisor, mentor, and investor in emerging ventures.